Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Oct;167(1):214-222.
doi: 10.1002/ijgo.15572. Epub 2024 May 13.

Progression of adenomyosis: Rate and associated factors

Giulia Borghese  1 , Marisol Doglioli  1   2 , Benedetta Orsini  1   2 , Antonio Raffone  2   3 , Daniele Neola  3 , Antonio Travaglino  4 , Giulia Rovero  1   2 , Simona Del Forno  1 , Lucia de Meis  1 , Mariavittoria Locci  3 , Maurizio Guida  3 , Jacopo Lenzi  5 , Renato Seracchioli  1   2 , Diego Raimondo  1
Affiliations
Observational Study

Progression of adenomyosis: Rate and associated factors

Giulia Borghese et al. Int J Gynaecol Obstet. 2024 Oct.

Abstract

Objective: To evaluate the rate of disease progression and the factors associated with such progression in patients with an ultrasound diagnosis of adenomyosis.

Methods: This was a single center, prospective, observational, cohort study performed at a tertiary referral center. Patients who obtained an ultrasound diagnosis of adenomyosis from May 2022 to August 2022 were recruited. Demographic, clinical and ultrasound data were recorded at the first visit (T0) and after 12 months (T1) for enrolled patients and compared between T0 and T1. The study population was divided in two groups according to progression (increase in uterine volume >20%) or stability/regression (decrease or increase in uterine volume ≤20%) of adenomyosis at T1. Primary study outcome was the rate of adenomyosis progression, while secondary study outcome was the association of adenomyosis progression with demographic and clinical factors. Post hoc subgroups analyses for primary and secondary study outcomes were performed based on hormonal therapy (untreated and treated).

Results: A total of 221 patients were enrolled in the study, with no significant difference in terms of baseline data among the two study groups and no patients were lost to follow-up. The overall rate of adenomyosis progression was 21.3% (47/221 patients). The rate was 30.77% in hormonally untreated women, and 18.34% in hormonally treated women. Progression was associated with the presence of focal adenomyosis of the outer myometrium (P = 0.037), moderate to severe dysmenorrhea (P = 0.001), chronic pelvic pain (P = 0.05), dyschezia (P = 0.05), and worsening of chronic pelvic pain (P = 0.04) at T1.

Conclusion: Adenomyosis showed a rate of disease progression of 21.3% at the 12-month follow-up (30.77% in hormonally untreated women, and 18.34% in hormonally treated women). The presence and/or worsening of painful symptoms, such as severe dysmenorrhea, dyschezia and chronic pelvic pain, as well as the presence focal adenomyosis of the outer myometrium, might help identify patients at higher risk of disease progression and tailor their follow-up.

Keywords: endometriosis; management; prognosis; size; sonography; uterus.

PubMed Disclaimer

References

REFERENCES

    1. van den Bosch T, Dueholm M, Leone FPG, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015;46(3):284‐298. doi:10.1002/uog.14806
    1. Liu L, Li W, Leonardi M, et al. Diagnostic accuracy of transvaginal ultrasound and magnetic resonance imaging for adenomyosis. J Ultrasound Med. 2021;40(11):2289‐2306. doi:10.1002/jum.15635
    1. da Silva JR, Andres MP, Leite APK, et al. Comparison of sensitivity and specificity of structured and narrative reports of transvaginal ultrasonogaphy for adenomyosis. J Minim Invasive Gynecol. 2021;28(6):1216‐1224. doi:10.1016/j.jmig.2020.11.001
    1. Andres MP, Borrelli GM, Ribeiro J, Baracat EC, Abrão MS, Kho RM. Transvaginal ultrasound for the diagnosis of adenomyosis: systematic review and meta‐analysis. J Minim Invasive Gynecol. 2018;25(2):257‐264. doi:10.1016/j.jmig.2017.08.653
    1. van den Bosch T, de Bruijn AM, de Leeuw RA, et al. Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet Gynecol. 2019;53(5):576‐582. doi:10.1002/uog.19096

Publication types

LinkOut - more resources